Endothelin-1 levels in interstitial lung disease patients during sleep.

被引:27
作者
Georgia Trakada
Eugenia Nikolaou
Athanasia Pouli
Maria Tsiamita
Kostas Spiropoulos
机构
[1] University of Patras Medical School, Division of Pulmonology, Laboratory of Sleep, Patras
关键词
Interstitial lung disease; sleep; endothelin-1 (ET-1); hypoxemia;
D O I
10.1007/s11325-003-0111-y
中图分类号
学科分类号
摘要
BACKGROUND: Hypoxemia stimulates endothelin-1 (ET-1) secretion. The reduction in alveolar ventilation during sleep is considered sufficient to account for the hypoxemia observed in patients with respiratory diseases. OBJECTIVE: The aim of this study was to evaluate the arterial ET-1 levels and their relationship with pulmonary hypertension in patients with interstitial lung disease (ILD) during sleep. METHODS: We examined 38 patients with ILD using formal polysomnography (electroencephalogram, electrocardiogram, airflow, respiratory muscle movement, oximeter) to detect the presence of nocturnal, nonapneic, oxyhemoglobin desaturation. All patients desaturated below a baseline sleep saturation of 90% for 5 minutes or more, reaching a nadir saturation of at least 85%. Each patient had already undergone right heart catheterization with a Swan-Ganz catheter for measuring hemodynamic parameters. Sampling of arterial blood from a radial artery line for determination of blood gases and ET-1 values was performed simultaneously, after 5 minutes of the first desaturation. RESULTS: At rest, arterial ET-1 levels were higher in ILD patients (1.73 +/- 0.37 mgr/mL) than in controls (1.22 +/- 0.15 mgr/mL) ( p < 0.001). Also, the patients with pulmonary hypertension (Pa > 20 mm Hg) presented significantly higher arterial ET-1 levels (1.86 +/- 0.32 mgr/mL) than those without pulmonary hypertension (1.31 +/- 0.13 mgr/mL) ( p < 0.001). Arterial ET-1 levels were significantly correlated with mean pulmonary arterial pressure (PAP) (r = 0.749, p < 0.001), and arterial oxygen partial pressure (PaO2) (r = 0.79, p < 0.001). At sleep, during desaturation, arterial ET-1 levels significantly increased in all patients (2.46 +/- 0.13 mgr/mL) as compared with resting values ( p < 0.001). Arterial ET-1 levels were significantly correlated with PAP (r = 0.657, p < 0.001) and PaO2 (r = 0.93, p < 0.001). CONCLUSIONS: According to our study, arterial ET-1 is markedly increased in ILD patients, especially in those with pulmonary hypertension.
引用
收藏
页码:111 / 118
页数:7
相关论文
共 109 条
[21]  
Wynne JW(2000)Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma Respir Med 10 992-996
[22]  
Block AJ(1993)Endothelin-1 in acute lung injury and the adult distress syndrome Am Rev Respir Dis 148 1646-1650
[23]  
Hemenway I(1989)Endothelin produces pulmonary vasoconstriction and systemic vasodilation J Appl Physiol 66 1008-1012
[24]  
Hunt LA(1995)Endothelin-1 synthesis, receptors and signal tranduction in alveolar epithelium: evidence for an autocrine role Am J Physiol 268 L192-L200
[25]  
Flick MR(1988)Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells FEBS Lett 238 249-252
[26]  
Trakada G(2001)Arterial endothelin-1 in interstitial lung disease patients with pulmonary hypertension Monaldi Arch Chest Dis 56 379-383
[27]  
Marangos M(1963)Respiration and wakefulness in man Acta Physiol Scand 59 1-110
[28]  
Spiropoulos K(1982)Respiration during sleep in normal man Thorax 37 840-844
[29]  
Francis PW(1983)Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome Am Rev Respir Dis 128 24-29
[30]  
Muller NL(1988)Breathing pattern and eye movement density during REM sleep in humans Am Rev Respir Dis 138 870-874